SwePub - search: id:"swepub:oai:DiVA.org:uu-135...

Enumeration	Reference	Cover	Find
1.	Alterman, Mathias (author) Development of selective non-peptide angiotensin II type 2 receptor agonsists 2010 In: jraas. Journal of the renin-angiotensin-aldosterone system. - : Hindawi Limited. - 1470-3203 .- 1752-8976. ; 11:1, s. 57-66 Journal article (peer-reviewed)abstract The development of the first drug-like selective angiotensin II type 2 (AT(2)) receptor agonist (22) derived from the non-selective angiotensin II type 1 (AT(1)) receptor/AT(2) receptor agonist L-162,313 is presented. Compound 22 with a K-i value of 0.4 nM for the AT(2) receptor and a K-i > 10 mu M for the AT(1) receptor induces outgrowth of neurite cells, stimulates p42/p44(mapk), enhancesin vivo duodenal alkaline secretion in Sprague-Dawley rats and lowers the mean arterial blood pressure in anaesthetised spontaneously hypertensive rats. Thus, the peptidomimetic 22 exerts a similar biological response as the endogenous peptide angiotensin II after selective activation of the AT(2) receptor. In addition, Compound 22 has a bioavailability of 20-30% after oral administration and a half-life estimated to four hours in the rat. Compound 22 will therefore serve as a valuable research tool enabling studies of the function of the AT(2) receptor in more detail.

Alterman, Mathias (author)
Development of selective non-peptide angiotensin II type 2 receptor agonsists
2010
In: jraas. Journal of the renin-angiotensin-aldosterone system. - : Hindawi Limited. - 1470-3203 .- 1752-8976. ; 11:1, s. 57-66
Journal article (peer-reviewed)abstract
- The development of the first drug-like selective angiotensin II type 2 (AT(2)) receptor agonist (22) derived from the non-selective angiotensin II type 1 (AT(1)) receptor/AT(2) receptor agonist L-162,313 is presented. Compound 22 with a K-i value of 0.4 nM for the AT(2) receptor and a K-i > 10 mu M for the AT(1) receptor induces outgrowth of neurite cells, stimulates p42/p44(mapk), enhancesin vivo duodenal alkaline secretion in Sprague-Dawley rats and lowers the mean arterial blood pressure in anaesthetised spontaneously hypertensive rats. Thus, the peptidomimetic 22 exerts a similar biological response as the endogenous peptide angiotensin II after selective activation of the AT(2) receptor. In addition, Compound 22 has a bioavailability of 20-30% after oral administration and a half-life estimated to four hours in the rat. Compound 22 will therefore serve as a valuable research tool enabling studies of the function of the AT(2) receptor in more detail.

Träfflista för sökning "id:"swepub:oai:DiVA.org:uu-135602" "